Halda Raises $126m For First Clinical Trial Of Its RIPTAC Modality

Heterobifunctional Molecules From A PROTAC Pioneer

 
• By Mandy Jackson
  
Venture capital. Long term business investment
Halda has raised $202m to date • Source: Shutterstock
Scrip Podcast

Have you checked out Scrip podcast?

New episodes every Thursday.

SpotifyApple PodcastsWebsite

More from Financing

More from Business